Plexus Corp. (NASDAQ:PLXS – Get Free Report) CFO Patrick John Jermain sold 3,361 shares of the stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $144.57, for a total transaction of $485,899.77. Following the transaction, the chief financial officer now directly owns 20,745 shares of the company’s stock, valued at $2,999,104.65. This represents a 13.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Patrick John Jermain also recently made the following trade(s):
- On Wednesday, November 6th, Patrick John Jermain sold 2,643 shares of Plexus stock. The shares were sold at an average price of $166.32, for a total value of $439,583.76.
Plexus Price Performance
PLXS stock opened at $143.42 on Thursday. The firm has a 50 day moving average of $161.50 and a 200-day moving average of $142.70. The firm has a market capitalization of $3.89 billion, a P/E ratio of 33.28 and a beta of 0.91. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $172.89. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07.
Hedge Funds Weigh In On Plexus
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PLXS. Quarry LP raised its holdings in shares of Plexus by 573.5% in the 3rd quarter. Quarry LP now owns 229 shares of the technology company’s stock valued at $31,000 after acquiring an additional 195 shares in the last quarter. R Squared Ltd bought a new stake in Plexus during the fourth quarter valued at approximately $45,000. Point72 DIFC Ltd purchased a new position in Plexus in the 3rd quarter worth approximately $51,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Plexus in the 3rd quarter worth $55,000. Finally, USA Financial Formulas purchased a new stake in shares of Plexus during the 4th quarter valued at $56,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. StockNews.com raised Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Needham & Company LLC lifted their target price on shares of Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Stifel Nicolaus upped their price target on shares of Plexus from $136.00 to $150.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. KeyCorp initiated coverage on shares of Plexus in a research note on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Finally, Benchmark reissued a “buy” rating and set a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $162.33.
Check Out Our Latest Analysis on PLXS
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Coinbase Gains Momentum on App Store—What It Means for the Stock
- What Are Dividend Champions? How to Invest in the Champions
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Basic Materials Stocks Investing
- 3 Steel Stocks Soaring After Tariff Announcements
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.